Literature DB >> 20695481

3'-Sulfo-Le(x) is important for regulation of integrin subunit alphaV.

Chun-Yi Zhang1, Ping Hu, Da Fu, Wei Wu, Cheng-You Jia, Xu Chao Zhu, Xing Zhong Wu.   

Abstract

Carbohydrate structures with a 3'-sulfo betaGal linkage, such as 3'-sulfo-Le(x), can be synthesized by Gal:3-O-sulfotransferase-2 (Gal3ST-2) catalysis, but little is known about their roles in many biological processes. To investigate the role of Gal3ST-2 and its product 3'-sulfo-Le(x), we depleted Gal3ST-2 via siRNA and added exogenous Lewis-x trisaccharide 3'-sulfate sodium salt in human SMMC7721 hepatoma cells. After siRNA transfection, a striking morphological change in SMMC7721 hepatoma cells from polygon to shuttle shape and a significant decrease in the level of adhesion to sL-selectin, HUVEC, fibronectin, vitronectin, and fibrinogen were observed. The expression of integrin subunit alphaV was markedly downregulated, and 3'-sulfated subunit alphaV almost disappeared in the transfectants. The level of cell surface integrin alphaVbeta3 was reduced simultaneously, although total subunit beta3 underwent almost no change. After treatment with exogenous Lewis-x 3'-sulfate, cellular integrin subunit alphaV was upregulated and the level of cell surface integrin alphaVbeta3 was elevated. Interestingly, knockdown of Gal3ST-2 expression effectively inhibited cell proliferation, and the result was significantly correlated with the decrease in the levels of ILK, phosphorylated AKT, and ERK. On the other hand, treatment with Lewis-x trisaccharide 3'-sulfate sodium salt greatly upregulated the phosphorylation of AKT and ERK. Our results also indicated that downregulation of Gal3ST-2 via siRNA transfection was associated with the decrease in the level of expression of anti-apoptotic protein, Bcl-2, with a consequent decrease in the ratios for Bcl-2 to Bax. By exposure to Lewis-x trisaccharide 3'-sulfate sodium salt, the apoptotic response of cells was inhibited. Therefore, Gal3ST-2 and its product, 3'-sulfo-Le(x), were involved in regulation of integrin subunit alphaV and might be associated with cancer cell regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695481     DOI: 10.1021/bi101040k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Roles of galactose 3'-O- sulfation in signaling.

Authors:  Rong Wang; Xing Zhong Wu
Journal:  Glycoconj J       Date:  2014-10-08       Impact factor: 2.916

2.  GAL3ST2 from mammary gland epithelial cells affects differentiation of 3T3-L1 preadipocytes.

Authors:  L N Guerra; C Suarez; D Soto; A Schiappacasse; D Sapochnik; P Sacca; G Piwien-Pilipuk; B Peral; J C Calvo
Journal:  Clin Transl Oncol       Date:  2014-12-23       Impact factor: 3.405

3.  Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells.

Authors:  Wei Wu; Yi Wei Dong; Peng Cheng Shi; Mei Yu; Da Fu; Chun Yi Zhang; Qian Qian Cai; Qian Lei Zhao; Ming Peng; Li Hui Wu; Xing Zhong Wu
Journal:  J Lipid Res       Date:  2013-01-22       Impact factor: 5.922

4.  SIN3B promotes integrin αV subunit gene transcription and cell migration of hepatocellular carcinoma.

Authors:  Qianqian Cai; Yuanyuan Liu; Ping Zhu; Chunlang Kang; Heyang Xu; Bing Qi; Rong Wang; Yiwei Dong; Xing Zhong Wu
Journal:  J Mol Cell Biol       Date:  2019-05-01       Impact factor: 6.216

5.  Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteins.

Authors:  Tanya R McKitrick; Steffen M Bernard; Alexander J Noll; Bernard C Collins; Christoffer K Goth; Alyssa M McQuillan; Jamie Heimburg-Molinaro; Brantley R Herrin; Ian A Wilson; Max D Cooper; Richard D Cummings
Journal:  Commun Biol       Date:  2021-06-03

6.  Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.

Authors:  Zhenhua Hu; Song Gao; Jian Gao; Rui Hou; Chuan Liu; Juanjuan Liu; Beibei Li; Dawo Liu; Shulan Zhang; Bei Lin
Journal:  Int J Mol Sci       Date:  2012-11-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.